Brazil and a Debate: Could Removing Patents Expedite Covid-19 Vaccination?

By positioning itself in favor of patents for the coronavirus, Brazil was contrary to its historical position that led the country to become a world pioneer in generic drugs. The issue resurfaces with vaccines.

RIO DE JANEIRO, BRAZIL - A debate that has gone virtually unnoticed in Brazilian foreign policy has returned to the spotlight this week. In October, India and South Africa proposed to the World Trade Organization (WTO) that there should be no trade sanctions on member countries that violate patents on drugs and vaccines against Covid-19.

The initiative came at a time when the results of the first vaccines against the virus that plagued the health of mankind and wore out economies emerged. The goal was to increase production capacity: production at the original manufacturers was limited and would hardly be . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?